| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | +42.0% |
| Cost of Revenue | $1.4M | +11.8% |
| Gross Profit | $215K | +280.3% |
| R&D Expense | $819K | +23.7% |
| SG&A Expense | $4.5M | +15.1% |
| Interest Expense | $3K | +0.0% |
| Net Income | -$7.8M | -16.6% |
| EPS (Basic) | -$5.19 | -723.8% |
| EPS (Diluted) | -$5.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -38.7% |
| Accounts Receivable | $108K | +15.8% |
| Inventory | $832K | +56.0% |
| Current Assets | $9.2M | +64.5% |
| Total Assets | $9.8M | +58.2% |
| Current Liabilities | $738K | +18.1% |
| Total Liabilities | $743K | +12.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | -16.9% |
| Capital Expenditures | $62K | -20.7% |
| Investing Cash Flow | -$5.2M | -2497.3% |
| Financing Cash Flow | $10.2M | +53.8% |
| Free Cash Flow | -$6.8M | -16.4% |
| -723.8% |
| Stockholders' Equity |
| $9.1M |
| +63.6% |